Iñaki F. Trocóniz

Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice

L. Buéno, Dinesh P. de Alwis, Celine Pitou et al. · European Journal of Cancer · 2007 · 202 citations

Medicine, Oncology, Pharmacology +15

Effects of the direct thrombin inhibitor dabigatran on <i>ex vivo</i> coagulation time in orthopaedic surgery patients: a population model analysis

Karl‐Heinz Liesenfeld, Hans Günter Schäfer, Iñaki F. Trocóniz et al. · British Journal of Clinical Pharmacology · 2006 · 115 citations · Full text

Medicine, Pharmacology, Surgery +17

Population Pharmacokinetic Analysis of the New Oral Thrombin Inhibitor Dabigatran Etexilate (BIBR 1048) in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Iñaki F. Trocóniz, Christiane Tillmann, Karl‐Heinz Liesenfeld et al. · The Journal of Clinical Pharmacology · 2007 · 97 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility

P.C. de Smidt, Miguel Ángel Campanero, Iñaki F. Trocóniz · International Journal of Pharmaceutics · 2003 · 80 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effects of Main Active Metabolites of Tramadol, (+)-O-Desmethyltramadol and (−)-O-Desmethyltramadol, in Rats

Marta Valle, Marı́a J. Garrido, Juan M. Pavón et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 70 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17